Drug Target Review2025-08-07T13:30:09
Johns Hopkins University scientists have engineered a new multi-region brain organoid that mimics early human brain development. The model offers a powerful new tool for studying disorders like autism, schizophrenia and Alzheimer’s disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2026-08-24T08:43:00
Author Dr Dana Watt
2026-06-01T07:00:00
Contributor Dr Timothy O’Connor, Drug Target Review
2023-04-17T14:45:00
Sponsored by Sartorius, Drug Target Review
2026-11-13T07:00:00
Contributor Dr Panos Roussos, Drug Target Review
2026-06-24T13:00:00
Sponsored by HUB Organoids
2023-04-12T15:15:18
Sponsored by Cellistic
Site powered by Webvision Cloud